To stay up to date with the latest news and publications from The Health Policy Partnership, make sure you're following us on LinkedIn!
https://t.co/iKcvW3g4R1
The Health Policy Partnership (HPP) is pleased to announce a new strategic partnership with @POLITICOEurope that aims to provide answers to some of the biggest questions in health policy.
https://t.co/AGtM6mez09
People with #MetastaticBreastCancer often experience inequitable care as breast cancer policy is skewed towards the earlier stages of the disease.
Hear from experts as they share actionable recommendations to reduce inequalities in care.
#bcsm https://t.co/Mz3uNw8da6
Last week, HPP Managing Director Ed Harding spoke with @theipaper to discuss how the UK’s NHS can safeguard services during global crises. https://t.co/crWAFp0kjr
To support the growing demand for #RadioligandTherapy, we’ve published a set of key performance indicators that set out targets for people applying our Radioligand Therapy Readiness Assessment Framework.
Find out more 👇https://t.co/dNA0Rv2M39
Care for #MetastaticBreastCancer (MBC) can be improved at all levels.
We explore how to achieve patient empowerment, the provision of tailored information, and greater involvement of people with MBC in policy development, research and care.
#bcsm
https://t.co/G2QcdYbYho
We are working with Testbed Sweden to support adoption of precision cancer medicine. Together, we’ve created a framework to ensure trials prepare the health system – generating evidence for clinical, regulatory, health-economic and reimbursement decisions. https://t.co/Ibn6Lxa1oK
Policy change can achieve equitable access to treatment and care for people with #MetastaticBreastCancer (MBC).
We examine ways to reduce inequalities in MBC care along the care pathway in a new policy brief.
#bcsm
https://t.co/ljl6BfoKUR
The PAH policy toolkit, developed by @HealthPolicyPtp in collaboration with 10 experts, supports advocates in communicating the case for change in pulmonary arterial hypertension to decision-makers. #ActionOnPAH
Find out more: https://t.co/RmzV7tXM0Q
Global Heart Hub is delighted to see its manifesto for early detection and early diagnosis of cardiovascular disease published this week in the European Heart Journal @escardio. The manifesto is the first patient-led, global patient perspective on the necessity of early detection and early diagnosis in CVD.
📜 Read the article here: https://t.co/4NVyWnVuOp
If adapted, the manifesto should guide political advocacy and shape improved health outcomes and foster greater sustainability of health systems.
The European Heart Journal article was authored by @fjpinto1960, Faculty of Medicine, University of Lisbon, Portugal; Ed Harding, @HealthPolicyPtp and Olive Fenton, Global Heart Hub.
In our recent article in @MediaplanetUK's Future of Healthcare issue, HPP Director of Research Jody Tate discussed the potential of AI to improve cancer care in the UK. #FutureOfHealthcareCampaign2024 https://t.co/FCOwf0bHoM
How can we address structural and systemic barriers to equitable metastatic breast cancer care?
Read our policy brief to find actionable recommendations for policymakers to reduce inequalities in #MetastaticBreastCancer care.
#bcsm
https://t.co/xEWEyRjRmu
Today marks the first #WilsonDiseaseAwarenessDay. Discover our resources highlighting the policy requirements needed to ensure that people with the disease receive the best possible care. https://t.co/NrcoBREVji
As part of the @LungPolicy#LungCancerAwarnessMonth activities, we were proud to have produced a report examining the impact that optimal management of incidental pulmonary nodules (IPNs) can have on the earlier detection of lung cancer. https://t.co/JLaLzseyZP
Policymakers must take immediate action to deliver high-quality care that is accessible for all people with #MetastaticBreastCancer (MBC).
We’ve published three new policy briefs with actionable recommendations to reduce inequalities MBC care.
#bcsm
https://t.co/BhVDjwckWy
1 in 5 people with pulmonary arterial hypertension (PAH) dies within three years of diagnosis, despite available treatments.
Our new policy toolkit provides a blueprint for change for PAH to enable people to get the care they need. #ActionOnPAH https://t.co/948Ye5zwbY
Last week, we hosted a webinar in which experts highlighted the key challenges and lessons learnt from implementing immunisation programmes to protect infants during RSV season.
The full recording can now be watched on our website. ▼
#RSV#immunisation
https://t.co/tzKmmmiNMz
Tobacco use is a major contributor to poor public health – yet policies to reduce smoking have met limited success.
In our latest blog post, HPP Senior Researcher Chris Melson discusses the tobacco endgame. ▼
https://t.co/OxKyrzK1eb
Today, as part of Breast Cancer Awareness Month, we have published the first in a set of policy briefs providing actionable recommendations for reducing inequalities in metastatic breast cancer care.
Read now: https://t.co/IyuCG4Tg7A
#bcsm